Biomarkers and Precision Medicine Community (BPMC)

 View Only
  • 1.  OSD Nov 2nd: Development of Companion Diagnostics for AAV Gene Therapy

    Community Leadership
    Posted 10-19-2023 21:00

    Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Gene and Cell Therapy Product (GCTP), Biomarkers and Precision Medicine (BPM) and BioAnalytical (BA) Communities on Nov 2, 2023, 12 pm – 1 pm EDT on the following topic:

    Development of Companion Diagnostics for AAV Gene Therapy

           Introduction to companion diagnostics (CDx) for AAV gene therapy

           Effect of pre-existing AAV immunity on gene therapy

           Biomarkers for patient enrollment into gene therapy trials and FDA guidance

           Pre-existing anti-AAV antibody assay formats

           Overview of CDx development process

           Regulatory strategies and landscape on gene therapy CDx development

           Regulatory strategies for Analytical and Clinical Validation

           FDA and EU regulatory landscape for Gene Therapy CDx

           Implementation of CDx for gene therapy

           The need for partnership

           Dx Partner engagement 

           Challenges of CDx development for gene therapy

    Discussion Leaders:

    Yanmei Lu (Sangamo Therapeutics), George Bashirians (CompanionDx Consulting), Maham Ansari (Precision For Medicine) and Natasha Thorne (FDA CDRH)

    Organized by:  

    Yanmei Lu (Sangamo Therapeutics), Yan Ni (Passage Bio), Karen Quadrini (Passage Bio), and Sanjeev Bhardwaj (Moderna)

    We start at 12:00 EDT sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

    (Please remain on mute unless asking questions) 

    When: Thursday, Nov 2, 2023, 12 pm – 1 pm EDT

    WherePlease join from your computer, tablet or smartphone.
    https://meet.goto.com/505947717

    You can also dial in using your phone.
    United States: 
    +1 (646) 749-3122
    Access Code: 505-947-717

    Join from a video-conferencing room or system.
    Dial in or type: 
    67.217.95.2 or inroomlink.goto.com
    Meeting ID: 505-947-717
    Or dial directly
    [email protected] or 67.217.95.2##505947717

    New to GoToMeeting? Get the app now and be ready when your first meeting starts:
    https://meet.goto.com/install

    Please feel free to share with colleagues who may be interested in this topic.

    Thank you,

    The Leadership Teams of the AAPS GCTP, BPM and BA Communities

    #OSD  #OpenScientificDiscussions  #genetherapy  #Immunogenicity  #Biomarkers  #Bioanalytical



    ------------------------------
    Karen Quadrini, PhD
    Director, Biomarkers and Precision Medicine
    Passage Bio
    Philadelphia, PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------


  • 2.  RE: OSD Nov 2nd: Development of Companion Diagnostics for AAV Gene Therapy

    Posted 10-20-2023 09:35

    This looks great, but I'm not sure I can attend! Any chance this OSD be recorded and then shared?



    ------------------------------
    Susan Irvin, PhD, PMP
    Regeneron Pharmaceuticals, Inc.

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------



  • 3.  RE: OSD Nov 2nd: Development of Companion Diagnostics for AAV Gene Therapy

    Community Leadership
    Posted 10-21-2023 20:40

    Hi Susan,

    Yes, a recording will become available after the event and posted in the community library.



    ------------------------------
    Karen Quadrini, PhD
    Director, Biomarkers and Precision Medicine
    Passage Bio
    Philadelphia, PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------